Compounded Semaglutide: Are Ozempic and Wegovy Knock-Offs Safe?

Whether it’s due to an ingredient allergy or other reasons, compounding pharmacies can help tailor a custom-made medication to meet your needs. And when drug shortages happen, they can play an important role, too.

Two semaglutide injections, Ozempic and Wegovy, were previously affected by shortages. Given the demand, some compounding pharmacies jumped at the opportunity to fill a medical need. By mixing up semaglutide injections from scratch, they could help people continue treatment until the shortage was over.

Under certain conditions, the FDA may allow pharmacies to make medications that are in shortage. But as of February 2025, the FDA declared that the semaglutide shortage was resolved. Even so, compounded semaglutide products may not disappear completely. In this case, compounded semaglutide may seem like a tempting alternative. But is it worth the risk?

What is compounded semaglutide?

Compounded semaglutide is a medication that’s custom-made for you by a compounding pharmacy. It contains the active ingredient semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is found in several FDA-approved medications: Ozempic, Wegovy (pen and pill), and Rybelsus.

Does this mean that compounded semaglutide is the same as Ozempic, Wegovy, or Rybelsus? The short answer: No. And these products are not “generic Ozempic” or “generic Wegovy.” Generic drugs are FDA approved and must show that they’re bioequivalent to the brand-name drug. There are no FDA-approved generics of these medications yet.

You may see compounded semaglutide in several different dosage forms, including:

• Injections

• Sublingual (under the tongue) drops

• Orally disintegrating tablets (ODTs)

• Oral capsules or tablets

• Nasal sprays

Compounded semaglutide medications are not FDA approved. Their safety and effectiveness haven’t been established. So it’s not guaranteed that you’ll get the same results with them as with the FDA-approved products.

Why is semaglutide being compounded?

Some pharmacies were compounding semaglutide injections to help people access treatment while Ozempic and Wegovy were in shortage. But as of February 2025, the FDA announced that the shortage is resolved. Rybelsus (oral semaglutide for Type 2 diabetes) was not affected by shortages and remains available. And as of January 2026, the Wegovy pill is also on the market.

Cost isn’t considered a valid reason for compounding copies of semaglutide medications when the FDA-approved product is available. And making small changes just to bypass FDA requirements isn’t allowed either. If you’ve been using compounded semaglutide, you may need to transition to Ozempic or Wegovy in order to continue treatment.

EXPERT PICKS: WHAT TO READ NEXT

• Making the switch: Are you switching from a compounded GLP-1 to an FDA-approved, brand-name GLP-1? Here’s how to navigate the process.

• How to save: Glucagon-like peptide-1 (GLP-1) medications don’t need to break the bank. Explore ways to save on Wegovy, Ozempic, Zepbound, and other GLP-1 medications.

• A natural boost: Medications like Wegovy work by mimicking the effects of a gut hormone called GLP-1. But did you know that there are foods and supplements that can increase GLP-1 naturally?

Compounded semaglutide vs. Ozempic and Wegovy

So what exactly is the difference between compounded semaglutide and Ozempic, Wegovy, and Rybelsus? Their testing and approval, ingredients, and dosage forms are a few differences to consider.

Testing and approval

Ozempic, Wegovy, and Rybelsus are all FDA-approved medications made by Novo Nordisk. This means they’ve gone through rigorous testing and review to ensure that they’re safe and effective for their intended uses. During the approval process, the FDA also evaluated where and how these medications are made.

Compounded semaglutide medications are made by specialized pharmacies that source ingredients and combine them to make a finished product. These medications are custom made. So they aren’t required to go through the same rigorous testing and approval process. This means they don’t have the same evidence for safety and efficacy as the commercial products.

Read more like this

Explore these related articles, suggested for readers like you.

Is Semaglutide in Shortage? The Latest on Ozempic and Wegovy Availability

Live Updates: Tracking Insurance Coverage for GIP and GLP-1 Agonists Like Zepbound and Wegovy

Rybelsus vs. Wegovy: 6 Differences You Should Know About

Ozempic: Uses, Side Effects, Dosage, & More

View more

Ingredients

When compounding semaglutide, pharmacies will use a recipe that’s likely different from Ozempic, Wegovy, or Rybelsus. The commercial medications serve as a reference, but there may be some minor changes in the inactive ingredients. This is typical with compounded medications.

But some compounded semaglutide medications may also contain extra ingredients that haven’t been tested with semaglutide, such as vitamin B12. It’s not fully known how these additions might affect the compounded medication. And in some cases, these extra ingredients are commercially available and can be administered separately if needed. So there may not be a medical need to add them to the compounded formula in the first place.

Concerns have also been raised about the ingredients used to make some compounded semaglutide products, including:

• Semaglutide salts: According to the FDA, semaglutide salts, such as semaglutide acetate, should not be used for compounding. They’re different from what’s contained in Ozempic, Wegovy, and Rybelsus, which are made with semaglutide base.

• Unauthorized sources: Semaglutide base must be manufactured by an FDA-registered facility in order to meet federal requirements. Some pharmacies may be purchasing semaglutide base from facilities that don’t meet this requirement, raising quality and safety concerns.

• Non-pharmaceutical grade ingredients: Some pharmacies may be purchasing semaglutide that’s labeled “for research use only” to make their compounds. These chemicals are unregulated and are not meant to be used in people. So they don’t meet the federal requirements for compounding.

Medication delivery and storage

Ozempic and Wegovy injections are only available as prefilled injection pens. Compounded semaglutide injections are usually dispensed in a vial. That means you’ll need to draw up your specific dose with a syringe prior to injecting it.

Storage requirements and shelf life will also likely be different with compounded semaglutide. This can depend on how the injections are made.

Dosages

Ozempic and Wegovy come in a limited number of standardized, pre-measured doses that have been extensively studied in clinical trials. And because these are FDA-approved products, every injection pen and pill is designed to deliver a consistent and predictable amount of semaglutide with each dose.

Compounded semaglutide, on the other hand, can be formulated to provide doses that are different from the commercial products. This includes “microdoses” — much smaller doses than those approved by the FDA. These products are often promoted as more customizable or easier to tolerate. But there isn’t evidence to support microdoses, and sticking with very low doses may not give you the same results you’d expect from standard doses.

Dosage forms

Ozempic and the Wegovy pen are injectable medications, while Rybelsus and the Wegovy pill are oral tablets. All four medications have been carefully formulated and tested to ensure their effectiveness and safety. And studies have been done to understand the expected levels of semaglutide in the body when taking these specific forms and doses.

Compounded semaglutide comes in a variety of dosage forms beyond injections. Semaglutide in the form of sublingual drops, ODTs, and nasal sprays hasn’t been studied in humans. There aren’t any FDA-approved versions of these dosage forms to use as a reference. And the absorption rate of semaglutide in these forms is not well understood. So it’s difficult to know what to expect from taking these medications.

Is compounded semaglutide safe and effective?

It’s not possible to say for certain. This is because the FDA doesn’t evaluate the safety and effectiveness of compounded medications. But that doesn’t mean that they’re ineffective or dangerous. Compounded medications have an important place in medicine. Yet, they also have their own unique risks.

Unlike drug manufacturers, compounding pharmacies are primarily regulated by state boards of pharmacy. Compounding regulations and the degree of oversight can vary by state. So not all compounding pharmacies are following the same set of quality standards. But some pharmacies may be accredited. This means that they’ve been found to meet a specific set of standards.

Some compounding pharmacies, known as outsourcing facilities, are registered with the FDA. These pharmacies are inspected by the FDA. They’re also required to follow stricter regulations called current good manufacturing practice regulations.

Keep in mind that the quality of compounded medications can vary across pharmacies. The pharmacy that fills your prescription, the ingredients they use, and how they make it matters.

What are the side effects and risks of using compounded semaglutide?

Compounded semaglutide may cause many of the same side effects as Ozempic and Wegovy. But keep in mind that these products aren’t the same across the board. They can also differ from FDA-approved forms in their dose, route of administration, and ingredients, which can influence potential side effects.

Common semaglutide side effects include:

• Nausea and vomiting

• Diarrhea or constipation

• Stomach pain

• Gas and bloating

• Fatigue

Rare but serious semaglutide side effects include:

• Very low blood sugar (glucose)

• Pancreatitis

• Gallbladder problems

• Gastroparesis (slowed stomach emptying)

• Acute (sudden) kidney damage

• Increased risk of certain types of thyroid tumors

Because of these side effects, some people may be advised to avoid GLP-1s like semaglutide altogether.

Risks specific to compounded semaglutide

In addition to the risks outlined above, there are other potential risks associated with using compounded semaglutide. Examples of these include:

• Inappropriate ingredients: As covered above, some pharmacies may be using ingredients that don’t meet FDA requirements. These ingredients may have unknown quality and purity. Or they may not work the same way as the original ingredient.

• Potential contamination: There are risks of contamination with compounded semaglutide injections, especially if they’re not made properly or in a sterile environment. One study found that about 45% of drug recalls over a roughly 10-year period were from compounding pharmacies. These recalls were mostly due to sterility concerns.

• Impurities: According to Novo Nordisk, compounded semaglutide products tested by the company were found to contain unknown impurities up to 33%.

• Quality control processes: Compounding pharmacies may not have the same rigorous quality control processes as drug manufacturers. This can be particularly risky if they’re producing a large volume of these compounded medications.

• Dosage errors: Compounded semaglutide vials don’t have the same safety features as the prefilled injection pens. So there can be a higher risk of injecting too much semaglutide. This may be more likely if you aren’t provided clear instructions with your prescription, or if you aren’t familiar with how to use a syringe to measure your dose.

Many of these risks are possible with any medication. But it’s especially important to be aware of them with compounded semaglutide. Working with an experienced, reputable pharmacy can help lower the risk of these potential issues.

What to look for when buying compounded semaglutide

As mentioned, compounded copies of semaglutide injections have been largely phased out. In most cases, your next step would be switching from compounded semaglutide to an FDA-approved product.

But if your prescriber believes that a custom compounded semaglutide product is medically necessary, here are a few things to look for in a pharmacy:

• Accreditation: Accredited pharmacies have been found to comply with national standards for compounding medications. This can provide another layer of reassurance. Examples of accreditation programs include those through the National Association of Boards of Pharmacy and the Pharmacy Compounding Accreditation Board. Outsourcing facilities can be another option to consider since they’re required to meet more stringent requirements.

• Proper licensing: The pharmacy should be properly licensed. The license(s) should be in a good standing — not expired, revoked, or have current disciplinary action. The pharmacy should also have a physical address and phone number in the U.S. For injections, some states require a separate sterile compounding license.

• Readily available staff: You should be able to call the pharmacy and speak with a licensed pharmacist to answer your questions. They can help you understand how to use your medication properly to avoid errors.

• False advertising: Be cautious of pharmacies or other companies advertising compounded semaglutide as “generic” versions of Ozempic or Wegovy. They also shouldn’t be making claims about compounded semaglutide’s effectiveness or safety.

• Prescription requirements: Compounded semaglutide always requires a prescription. Steer clear from pharmacies that will sell you semaglutide without one. There’s a chance you could receive a counterfeit product.

The information covered above may not be readily available to you. So if you have any questions or want more information, contact the pharmacy. They can tell you about their ingredient sources, what’s in your medication, quality control processes, and more.

How to switch to FDA-approved semaglutide

But what should you do if you need to switch from compounded semaglutide to Ozempic or Wegovy? Here are a few tips to help make the transition as smooth as possible.

• Talk to your healthcare team. They can help determine whether Ozempic or Wegovy is the right fit for your needs. If needed, they can also discuss potential alternatives.

• Check your insurance coverage. Your prescriber may need to submit a prior authorization or documentation to help you get coverage.

• Explore savings programs. If you're new to using GoodRx for semaglutide savings, pay an introductory price for the first two fills: $199 per month for Ozempic or Wegovy injections, or $149 for the Wegovy pill (only available for certain doses). After that, most ongoing fills are $299 or $349 per month, depending on the medication and dose. You may also be eligible for a manufacturer copay card or patient assistance program through Ozempic and Wegovy’s manufacturer.

If you’re unsure where to start, your healthcare team can help you navigate the next steps. Also know that subscribers to GoodRx for Weight Loss can also access FDA-approved, brand-name GLP-1 medications.

Frequently asked questions

Why trust our experts?

Written by:

Alyssa Billingsley, PharmD

Alyssa Billingsley, PharmD, is the director of pharmacy content for GoodRx. She has over a decade of experience as a pharmacist and has worked in clinical, academic, and administrative roles.

Reviewed by:

Stacia Woodcock, PharmD

Stacia Woodcock, PharmD, is a pharmacy editor for GoodRx. She earned her Doctor of Pharmacy degree from the University of Kentucky and is licensed in New York and Massachusetts.

Our editorial standards

Meet our experts